These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


438 related items for PubMed ID: 17425746

  • 1. Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.
    Kim I, Keam B, Lee KH, Kim JH, Oh SY, Ra EK, Yoon SS, Park SS, Kim CS, Park S, Hong YC, Kim BK.
    Clin Transplant; 2007; 21(2):207-13. PubMed ID: 17425746
    [Abstract] [Full Text] [Related]

  • 2. Influence of glutathione S-transferase A1, P1, M1, T1 polymorphisms on oral busulfan pharmacokinetics in children with congenital hemoglobinopathies undergoing hematopoietic stem cell transplantation.
    Elhasid R, Krivoy N, Rowe JM, Sprecher E, Adler L, Elkin H, Efrati E.
    Pediatr Blood Cancer; 2010 Dec 01; 55(6):1172-9. PubMed ID: 20672371
    [Abstract] [Full Text] [Related]

  • 3. Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver: consequences for enzyme expression and busulfan conjugation.
    Bredschneider M, Klein K, Mürdter TE, Marx C, Eichelbaum M, Nüssler AK, Neuhaus P, Zanger UM, Schwab M.
    Clin Pharmacol Ther; 2002 Jun 01; 71(6):479-87. PubMed ID: 12087351
    [Abstract] [Full Text] [Related]

  • 4. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul 01; 28(7):545-8. PubMed ID: 17147125
    [Abstract] [Full Text] [Related]

  • 5. Lack of IFN-gamma 2/2 homozygous genotype independently of recipient age and intensity of conditioning regimen influences the risk of aGVHD manifestation after HLA-matched sibling haematopoietic stem cell transplantation.
    Mlynarczewska A, Wysoczanska B, Karabon L, Bogunia-Kubik K, Lange A.
    Bone Marrow Transplant; 2004 Aug 01; 34(4):339-44. PubMed ID: 15235581
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK, Parikh PM, Tawde S, Amare-Kadam PS, Rajadhyaksha S, Chhaya S.
    Natl Med J India; 2004 Aug 01; 17(2):71-3. PubMed ID: 15141598
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [HLA-identical sibling allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia in first chronic phase. Analysis of 51 cases].
    He Y, Feng SZ, Wang M, Wei JL, Qin TJ, Zhou Z, Zhai WJ, Qiu LG, Han MZ.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jul 01; 26(7):389-92. PubMed ID: 16251016
    [Abstract] [Full Text] [Related]

  • 13. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Jin JY, Lee JW, Kim CC.
    Biol Blood Marrow Transplant; 2009 Jun 01; 15(6):704-17. PubMed ID: 19450755
    [Abstract] [Full Text] [Related]

  • 14. The impact of HLA-E polymorphisms in graft-versus-host disease following HLA-E matched allogeneic hematopoietic stem cell transplantation.
    Hosseini E, Schwarer AP, Ghasemzadeh M.
    Iran J Allergy Asthma Immunol; 2012 Mar 01; 11(1):15-21. PubMed ID: 22427472
    [Abstract] [Full Text] [Related]

  • 15. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
    Zhang XH, Huang XJ, Liu KY, Xu LP, Liu DH, Chen H, Chen YH, Wang JZ, Han W, Lu DP.
    Chin Med J (Engl); 2007 Mar 20; 120(6):463-8. PubMed ID: 17439737
    [Abstract] [Full Text] [Related]

  • 16. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
    Okumura H, Yamaguchi M, Kotani T, Sugimori N, Sugimori C, Ozaki J, Kondo Y, Yamazaki H, Chuhjo T, Takami A, Ueda M, Ohtake S, Nakao S.
    Eur J Haematol; 2007 Feb 20; 78(2):157-60. PubMed ID: 17313562
    [Abstract] [Full Text] [Related]

  • 17. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
    Moore J, Nivison-Smith I, Goh K, Ma D, Bradstock K, Szer J, Durrant S, Schwarer A, Bardy P, Herrmann R, Dodds A.
    Biol Blood Marrow Transplant; 2007 May 20; 13(5):601-7. PubMed ID: 17448920
    [Abstract] [Full Text] [Related]

  • 18. Association of IL-1β -511 polymorphism with severe veno-occlusive disease in pediatric-matched allogeneic hematopoietic stem cell transplantation.
    Elbahlawan L, McArthur J, Quasney MW, Pei D, Srivastava K, Dahmer MK, Barfield R.
    J Pediatr Hematol Oncol; 2012 Apr 20; 34(3):175-9. PubMed ID: 22395218
    [Abstract] [Full Text] [Related]

  • 19. Glutathione S-transferase polymorphisms are not associated with population pharmacokinetic parameters of busulfan in pediatric patients.
    Zwaveling J, Press RR, Bredius RG, van Derstraaten TR, den Hartigh J, Bartelink IH, Boelens JJ, Guchelaar HJ.
    Ther Drug Monit; 2008 Aug 20; 30(4):504-10. PubMed ID: 18641537
    [Abstract] [Full Text] [Related]

  • 20. Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation.
    Elmaagacli AH, Koldehoff M, Landt O, Beelen DW.
    Bone Marrow Transplant; 2008 May 20; 41(9):821-6. PubMed ID: 18209723
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.